West Pharmaceutical Services Inc
(STU:WPS)
€
312
1.9 (0.61%)
Market Cap: 22.88 Bil
Enterprise Value: 22.71 Bil
PE Ratio: 48.90
PB Ratio: 8.68
GF Score: 90/100 West Pharmaceutical Services Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Aug 16, 2023 / 10:00PM GMT
Release Date Price:
€364.6
(-0.57%)
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
So thanks for -- welcome to the UBS 2023 conference here. I'm John Sourbeer, UBS's life science analyst. Happy to host the fireside today with West Pharmaceuticals. Joining me is CEO and President, Eric Green; and VP of Investor Relations, Quintin Lai. Thanks for attending here.
Eric M. Green
West Pharmaceutical Services, Inc. - Chair, President & CEO
Yes, John, thanks for having us. It's been a really good day here at UBS. So thank you.
Questions & Answers
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
Great. So maybe start off here, high-level question. I know you guys reported earnings a couple of weeks ago, but on the demand environment, the company continues to see strong demand really across this proprietary product segment and the broader portfolio despite macro headwinds seen by peers and others within biologics or [larger] biopharma life science tools. So I guess
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot